• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

DOPAMINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

TP53 APOPTOTIC PROCESS IL17A RECEPTOR AGING STREPTOCOCCUS PNEUMONIAE LISTERIA MONOCYTOGENES REMICADE FOXP3 CD4 INFLAMMATION CELL PROLIFERATION CASP3 ALZHEIMER'S DISEASE INSULIN CELL DIVISION PSEUDOMONAS AERUGINOSA 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE IL6 ERBB-2 TH17 CELLS PORPHYROMONAS GINGIVALIS RHEUMATOID ARTHRITIS DOXORUBICIN IFNG CELL DEATH CANDIDA ALBICANS CTLA4 SOD1 BREAST CANCER AUTOPHAGY IMMUNE RESPONSE CLOSTRIDIUM DIFFICILE HELICOBACTER PYLORI PARKINSON DISEASE ANGIOGENESIS ESCHERICHIA COLI DIABETES MELLITUS CANCER TNF CELL DIFFERENTIATION IL23A METFORMIN STAPHYLOCOCCUS AUREUS NEURODEGENERATIVE DISORDERS

© 2020 Biovista Vizit All Rights Reserved.